Belumosudil and Rituximab for Primary Treatment of Chronic Graft-Versus-Host-Disease

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Belumosudil and Rituximab for Primary Treatment of Chronic Graft-Versus-Host-Disease	Bronchiolitis Obliterans, bronchial disorder, bronchiolitis, bronchiolitis obliterans syndrome, bronchitis, cryptogenic organizing pneumonia, graft versus host disease, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder	Recruiting	Phase 2	2026-04-20		NCT06046248

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Northside Hospital, Inc.	9
Sanofi	254

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Northside Hospital	Atlanta	United States	134

Clinical trials